Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.

Source:http://linkedlifedata.com/resource/pubmed/id/18949058

Download in:

View as

General Info

PMID
18949058